| 摘要 |
PCT No. PCT/US92/10886 Sec. 371 Date Oct. 18, 1994 Sec. 102(e) Date Oct. 18, 1994 PCT Filed Dec. 21, 1992Compounds of the formula <IMAGE> (I) the pharmaceutically acceptable salts thereof wherein R2, R3, R4, m, X and Q are as defined below, and novel intermediates used in the synthesis of such compounds. The compounds of formula I are inhibitors of acyl coenzyme A: cholesterol acyltransferase (ACAT) and are useful as hypolipidemic and antiatherosclerosis agents.
|
